SYSTEMATIC REVIEW
Published on 08 Jan 2025
Real-world effectiveness of Sofosbuvir/Velpatasvir, Glecaprevir/Pibrentasvir, and Sofosbuvir/Velpatasvir/Voxilaprevir against genotype 3 HCV infection: a systematic review and meta-analysis
doi 10.3389/fgstr.2025.1511150